Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Cameron

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Current Medical Research and Opinion|March 30, 2020
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosisImtiaz A Samjoo, Evelyn Worthington, Anja Haltner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2018
Acquisition of Multidrug-resistant Organisms in the Absence of AntimicrobialsErika M C D'Agata, Aby Varu, Sara F Geffert, et al.
Journal of Comparative Effectiveness Research|February 25, 2021
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancerHope S Rugo, Anja Haltner, Lin Zhan, et al.
Clinical Rheumatology|May 6, 2020
Propensity score matching/reweighting analysis comparing intravenous golimumab to infliximab for ankylosing spondylitis using data from the GO-ALIVE and ASSERT trialsL S Gensler, S D Chakravarty, Chris Cameron, et al.
The New Zealand Medical Journal|October 9, 2025
Eating disorders on medical wards: breaching clinical standards, patient rights and scopes of practiceCindy Towns, Vuk Sekicki, Kay Hodgetts, et al.
Breast (Edinburgh, Scotland)|March 7, 2021
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysisElizabeth M Salvo, Abril Oliva Ramirez, Jenilee Cueto, et al.
Future Oncology (London, England)|March 5, 2021
CDK4/6 inhibitors in HR+/HER2- advanced/metastatic breast cancer: a systematic literature review of real-world evidence studiesNadia Harbeck, Meaghan Bartlett, Dean Spurden, et al.
Archives of Osteoporosis|August 15, 2020
The burden of osteoporosis in Turkey: a scorecard and economic modelRima Aziziyeh, Javier Garcia Perlaza, Najma Saleem, et al.
Journal of Comparative Effectiveness Research|October 3, 2018
Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasisChris Cameron, Brian Hutton, Cheryl Druchok, et al.
Systematic Reviews|November 6, 2015
Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunitiesChris Cameron, Bruce Fireman, Brian Hutton, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Current Medical Research and Opinion|March 30, 2020
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosisImtiaz A Samjoo, Evelyn Worthington, Anja Haltner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2018
Acquisition of Multidrug-resistant Organisms in the Absence of AntimicrobialsErika M C D'Agata, Aby Varu, Sara F Geffert, et al.
Journal of Comparative Effectiveness Research|February 25, 2021
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancerHope S Rugo, Anja Haltner, Lin Zhan, et al.
Clinical Rheumatology|May 6, 2020
Propensity score matching/reweighting analysis comparing intravenous golimumab to infliximab for ankylosing spondylitis using data from the GO-ALIVE and ASSERT trialsL S Gensler, S D Chakravarty, Chris Cameron, et al.
The New Zealand Medical Journal|October 9, 2025
Eating disorders on medical wards: breaching clinical standards, patient rights and scopes of practiceCindy Towns, Vuk Sekicki, Kay Hodgetts, et al.
Breast (Edinburgh, Scotland)|March 7, 2021
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysisElizabeth M Salvo, Abril Oliva Ramirez, Jenilee Cueto, et al.
Future Oncology (London, England)|March 5, 2021
CDK4/6 inhibitors in HR+/HER2- advanced/metastatic breast cancer: a systematic literature review of real-world evidence studiesNadia Harbeck, Meaghan Bartlett, Dean Spurden, et al.
Archives of Osteoporosis|August 15, 2020
The burden of osteoporosis in Turkey: a scorecard and economic modelRima Aziziyeh, Javier Garcia Perlaza, Najma Saleem, et al.
Journal of Comparative Effectiveness Research|October 3, 2018
Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasisChris Cameron, Brian Hutton, Cheryl Druchok, et al.
Systematic Reviews|November 6, 2015
Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunitiesChris Cameron, Bruce Fireman, Brian Hutton, et al.
Pageof 8